Department of Anesthesiology, Critical Care and Perioperative Medicine, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.
Physiology Laboratory, Faculté de Médecine, Equipe Acceuil 3072, Strasbourg, France.
Sci Rep. 2023 Aug 28;13(1):14085. doi: 10.1038/s41598-023-40673-w.
Patient reported outcomes measures (PROMS) are important endpoints to measure patient health status in the perioperative setting. However, there are no good tools to measure PROMS in the pediatric surgical population. Patients 7 to 17 years old undergoing surgery were included and followed up for 1 day after surgery (POD1). At POD1 the patients were asked to rate their overall postoperative recovery using a 100-mm visual analog scale (VAS). The primary outcome was the pediatric QoR-15 score on postoperative day 1 (POD1). 150 patients completed the study. The mean (SD) pediatric QoR-15F scores were 132.1 (14.1) and 111.0 (27.0), preoperatively and on POD1, respectively. Convergent validity confirmed with Pearson (r) correlation between the postoperative pediatric QoR-15F and the patient-rated global recovery assessment was 0.72 (95% confidence interval [0.63-0.79]; p < 10). Concerning reliability, internal consistency of the pediatric QoR-15 assessed by Cronbach's alpha was 0.90. The test-retest concordance correlation coefficient was 0.92; 95% CI [0.83-0.96]. Split-half alpha was 0.74. The pictorial pediatric version of the QoR-15F showed good validity, reliability, responsiveness, acceptability and feasibility. This PROMS should be considered for clinical care and research in the perioperative pediatric patient setting.Trial Registration: NCT04453410 on clinicaltrials.gov.
患者报告结局测量(PROMs)是衡量围手术期患者健康状况的重要终点。然而,目前还没有很好的工具来测量小儿外科患者的 PROMs。纳入了 7 至 17 岁接受手术的患者,并在术后 1 天(POD1)进行随访。在 POD1,患者被要求使用 100mm 视觉模拟量表(VAS)对整体术后恢复情况进行评分。主要结局是术后第 1 天(POD1)的小儿 QoR-15 评分。150 名患者完成了研究。小儿 QoR-15F 的平均(SD)得分分别为 132.1(14.1)和 111.0(27.0),分别为术前和 POD1。术后小儿 QoR-15F 与患者对整体恢复评估的 Pearson(r)相关性的一致性效度证实为 0.72(95%置信区间[0.63-0.79];p<0.001)。关于可靠性,Cronbach's alpha 评估的小儿 QoR-15 的内部一致性为 0.90。测试-重测一致性相关系数为 0.92;95%CI[0.83-0.96]。两半信度系数为 0.74。小儿 QoR-15 的图像版显示出良好的有效性、可靠性、反应性、可接受性和可行性。该 PROMs 应考虑用于围手术期小儿患者的临床护理和研究。
NCT04453410 在 clinicaltrials.gov。